Debiopharm

Basic Information

• Category: pharmaceutical industry
• Website: https://www.debiopharm.com/

Documented Facts

• Team Size: 420 (No linked source recorded for this statement.)

Evidence and Sources

• Debiopharm — Official Site (official)
• Debiopharm on facebook (social)
• Debiopharm on linkedin (social)

Citation Guidance

Explore pharmaceutical industry profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Debiopharm.

• Canonical profile: https://brandsource.ai/brands/debiopharm
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/debiopharm/json-ld
• Citation profile API: https://brandsource.ai/api/brands/debiopharm/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Enriched
• Profile completeness: Source-backed profile (85/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2026-04-21

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.

Available profile information

• Official website is captured for entity disambiguation.
• 1 official source linked for verification.
• 2 supporting sources linked.
• 1 structured fact available for extraction.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.